Belite Bio (BLTE) Operating Leases (2022 - 2025)

Belite Bio (BLTE) posted quarterly Operating Leases of $188000.0 for Q4 2025, down 27.97% year-over-year from $261000.0 in Q4 2024, and down 23.27% quarter-over-quarter from $245000.0 in Q3 2025.

Belite Bio (BLTE) Operating Leases (2022 - 2025) Analysis & Trends

Belite Bio's Operating Leases history runs 4 years deep, the most recent figure standing at $188000.0 for Q4 2025.

  • In Q4 2025, Operating Leases fell 27.97% year-over-year to $188000.0; the TTM figure through Dec 2025 stood at $188000.0 (down 27.97% YoY), while the FY2025 annual figure was $188000.0, down 27.97% from the prior year.
  • Operating Leases for Q4 2025 stood at $188000.0, down from $245000.0 in the prior quarter.
  • The five-year high for Operating Leases was $668000.0 in Q4 2022, with the low at $188000.0 in Q4 2025.
  • The 4-year median for Operating Leases is $261000.0 (2024), against an average of $388000.0.
  • The sharpest annual moves came in 2023 and 2024: Operating Leases slipped 13.47% in 2023, then tumbled 54.84% in 2024.
  • Belite Bio's Operating Leases stood at $668000.0 in 2022, then retreated by 13.47% to $578000.0 in 2023, then sank by 54.84% to $261000.0 in 2024, then fell by 27.97% to $188000.0 in 2025.
  • Business Quant data shows BLTE's Operating Leases at $188000.0 in Q4 2025, $245000.0 in Q3 2025, and $261000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Belite Bio 6.40 Bn 6.40 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 188,000.00
Sep 30, 2025 245,000.00
Dec 31, 2024 261,000.00
Dec 31, 2023 578,000.00
Dec 31, 2022 668,000.00